Gridai (GRDX) traded down -0.98 % during a 24 hours period ending at 12:53 PM Central Europe on Tuesday 27th. One Gridai stock can currently be bought for about USD 5.55 on popular exchanges. Current supply of Gridai stocks is 7.1 mn. Gridai has a current market capitalization of USD 40 mn and approximately USD 311.4 k worth of Gridai was traded on exchanges in the last 24 hours. Since last month end, Gridai has traded 59.94 % up. Simple moving average of last 200 days is at USD 3.49. The highest price of past 52 weeks was recorded at USD 6.93 on 06/01/2026. 52 weeks low was at USD 1.87 on 03/24/2026.
Here is how related stocks have performed in the past 24 hours:
Spectral Ai (MDAI) traded up 4.17 % and now trades at USD 1.5. Current market capitalisation for Spectral Ai is USD 47.6 mn.
Myomo (MYO) traded down -0.83 % and now trades at USD 1.2. Myomo has a market capitalisation of USD 47.7 mn.
Apollomics (APLM) traded down -8.88 % and now trades at USD 19.9. Apollomics has a market capitalisation of USD 48 mn.
Werewolf Therapeutics (HOWL) traded up 0.1 % and now trades at USD 0.98. Werewolf Therapeutics has a market capitalisation of USD 47.6 mn.
Sensus Healthcare (SRTS) traded down -4.41 % and now trades at USD 2.82. Current market capitalisation for Sensus Healthcare is USD 47.7 mn.
About Gridai
First Wave BioPharma, Inc. is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. As a customer-oriented biotechnology industry player, First Wave BioPharma Inc. offers its services in the United States and France. You can learn more about their activities and offerings by visiting their website at www.firstwavebio.com . The company’s stock is traded on the Nasdaq stock exchange and it went public on 11th October 2016.